Also, suppressing TRF1 in mouse cells reduces glioblastoma and lung cancer progression without affecting normal cell viability or tissue health, while inhibiting TRF1 with ETP47228 and ETP47037 prevented TRF1 binding to telomeres and similarly halted cancer progression [132,133,134]. This evidence concerns the gene TERF1 and lung carcinoma.